Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes

被引：16
|
作者：
Kewan, Tariq [1 ,2 ]
Bahaj, Waled [1 ]
Durmaz, Arda [1 ,3 ]
Aly, Mai [1 ,4 ]
Ogbue, Olisaemeka D. [1 ]
Carraway, Hetty E. [1 ]
Sekeres, Mikkael A. [5 ]
Visconte, Valeria [1 ]
Gurnari, Carmelo [1 ,6 ]
Maciejewski, Jaroslaw P. [1 ,7 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH USA
[2] Yale Univ, Dept Hematol & Oncol, New Haven, CT USA
[3] Case Western Reserve Univ, Sch Med, Syst Biol & Bioinformat Dept, Cleveland, OH USA
[4] Assiut Univ, Fac Med, Assiut, Egypt
[5] Univ Miami, Dept Hematol & Oncol, Miami, FL USA
[6] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy
[7] Taussig Canc Inst, Dept Translat Hematol & Oncol Res, 9620 Carnegie Ave,N Bldg,Bldg NE6-250, Cleveland, OH 44106 USA
来源：
BLOOD | 2023年 / 141卷 / 14期
关键词：
MUTATIONS;
D O I：
10.1182/blood.2022018896
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1768 / 1772
页数：5
相关论文
共 50 条
  • [41] International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg, P
    Cox, C
    LeBeau, MM
    Fenaux, P
    Morel, P
    Sanz, G
    Sanz, M
    Vallespi, T
    Hamblin, T
    Oscier, D
    Ohyashiki, K
    Toyama, K
    Aul, C
    Mufti, G
    Bennett, J
    BLOOD, 1997, 89 (06) : 2079 - 2088
  • [42] Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System
    van Spronsen, Margot F.
    Ossenkoppele, Gert J.
    Westers, Theresia M.
    van de Loosdrecht, Arjan A.
    EUROPEAN JOURNAL OF CANCER, 2016, 56 : 10 - 20
  • [43] Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation
    Wang, Hong
    Li, Xueqian
    Qi, Jiaqian
    Liu, Hong
    Chu, Tiantian
    Xu, Xiaoyan
    Qiu, Huiying
    Fu, Chengcheng
    Tang, Xiaowen
    Ruan, Changgeng
    Wu, Depei
    Han, Yue
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1899 - 1909
  • [44] A five parameter based flow cytometric scoring system refines the revised International Prognostic Scoring System for myelodysplastic syndromes
    Alhan, C.
    Westers, T. M.
    Cremers, E. M. P.
    Cali, C.
    Ossenkoppele, G. J.
    Van de Loosdrecht, A. A.
    LEUKEMIA RESEARCH, 2013, 37 : S64 - S64
  • [45] A Revised International Prognostic Scoring System of 3.5 Points Stratifies Patients with Myelodysplastic Syndromes into 2 Risk Categories
    Montoro, Maria Julia
    Ortega, Margarita
    Villacampa, Guillermo
    Bernal, Teresa
    Pomares, Helena
    Castera, Elvira Mora
    Vilorio, Laura
    Tormo, Mar
    Diaz-Beya, Marina
    Brayan, Merchan
    Jerez, Andres
    Rivero, Eugenia
    Lys, Maria Jose
    Carcel, Paula
    Bargay, Joan
    Ramos, Fernando
    Xicoy, Blanca
    Diez-Campelo, Maria
    Valcarcel, David
    BLOOD, 2020, 136
  • [46] The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes
    Nazha, Aziz
    Seastone, David P.
    Keng, Michael
    Hobson, Sean
    Kalaycio, Matt
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3437 - 3439
  • [47] Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in TherapyRelated Myelodysplastic Syndromes
    Aguirre, Luis E.
    Al Ali, Najla
    Ball, Somedeb
    Singh, Avani M.
    Jain, Akriti G.
    Chan, Onyee
    Schwabkey, Zaker, I
    Tinsley-Vance, Sara M.
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2022, 140 : 9813 - 9815
  • [48] Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
    Creignou, Maria
    Bernard, Elsa
    Gasparini, Alessandro
    Tranberg, Anna
    Todisco, Gabriele
    Moura, Pedro Luis
    Ejerblad, Elisabeth
    Nilsson, Lars
    Garelius, Hege
    Antunovic, Petar
    Lorenz, Fryderyk
    Rasmussen, Bengt
    Walldin, Gunilla
    Mortera-Blanco, Teresa
    Jansson, Monika
    Tobiasson, Magnus
    Elena, Chiara
    Ferrari, Jacqueline
    Galli, Anna
    Pozzi, Sara
    Malcovati, Luca
    Edgren, Gustaf
    Crowther, Michael J.
    Jaedersten, Martin
    Papaemmanuil, Elli
    Hellstroem-Lindberg, Eva
    JOURNAL OF INTERNAL MEDICINE, 2024, 296 (01) : 53 - 67
  • [49] Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in Hypoplastic Myelodysplastic Syndromes
    Aguirre, Luis E.
    Al Ali, Najla
    Ball, Somedeb
    Singh, Avani M.
    Jain, Akriti G.
    Chan, Onyee
    Schwabkey, Zaker, I
    Tinsley-Vance, Sara M.
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2022, 140 : 6909 - 6911
  • [50] Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Underwent Allogenic Stem Cell Transplantation (HSCT)
    Kewan, Tariq
    Bewersdorf, Jan Philipp
    Blaha, Ondrej
    Stahl, Maximilian
    Al Ali, Najla H.
    DeZern, Amy E.
    Sekeres, Mikkael A.
    Uy, Geoffrey L.
    Carraway, Hetty E.
    Desai, Pinkal
    Griffiths, Elizabeth A.
    Stein, Eytan M.
    Brunner, Andrew M.
    Amaya, Maria L.
    Zeidner, Joshua F.
    Savona, Michael R.
    Stempel, Jessica M.
    Chandhok, Namrata Sonia
    Logothetis, Constantine
    Cochran, Hunter
    Rose, Ameera
    Roboz, Gail J.
    Wang, Eunice S.
    Rolles, Benjamin
    Harris, Amyah C.
    Shallis, Rory M.
    Xie, Zhuoer
    Padron, Eric
    Maciejewski, Jaroslaw P.
    Sallman, David A.
    Della Porta, Matteo Giovanni
    Komrokji, Rami S.
    Zeidan, Amer M.
    BLOOD, 2023, 142
12345